We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geogr... Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 3.6 trillion in fiscal 2021. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada. Show more
当社代表取締役社長CEOのクリストフ・ウェバーが12年間の勤務を経て、2026年6月に当社から退任 数年にわたる後継者計画プロセスを経て、U.S. ビジネスユニットプレジデントのジュリー・キムをウェバー氏の後任...
Revenue Growth of +9.8% at Actual Exchange Rates (AER); +4.5% at Constant Exchange Rate (CER) Driven by Strong Momentum of Growth & Launch Products (+14.6% at CER) Core Operating Profit...
Héma-Québec to Reimburse HyQvia® for the Treatment of Immunodeficiencies in Adult and Pediatric Patients Over 2 Years of Age Canada NewsWire TORONTO, Jan. 29, 2025 TORONTO, Jan...
Takeda a été nommée au palmarès des meilleurs employeurs au Canada pour une troisième année consécutive Canada NewsWire TORONTO, le 21 janv. 2025 Cette...
Santé Canada accorde à Takeda une autorisation de mise en marché de FRUZAQLA (MC) (fruquintinib) pour le traitement du cancer colorectal métastatique (CCRm) Canada...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.47 | 3.63777089783 | 12.92 | 13.88 | 12.92 | 2283117 | 13.41266156 | DR |
4 | 0.14 | 1.05660377358 | 13.25 | 13.88 | 12.86 | 2186601 | 13.20701639 | DR |
12 | -0.39 | -2.83018867925 | 13.78 | 14.03 | 12.86 | 1851449 | 13.36162393 | DR |
26 | -0.18 | -1.32645541636 | 13.57 | 15.08 | 12.86 | 1854976 | 13.91067113 | DR |
52 | -1.31 | -8.91156462585 | 14.7 | 15.08 | 12.575 | 1828444 | 13.80416398 | DR |
156 | -1.01 | -7.01388888889 | 14.4 | 17.15 | 12.28 | 2201477 | 14.50048593 | DR |
260 | -6.05 | -31.121399177 | 19.44 | 20.4844 | 12.28 | 2166684 | 15.36344477 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions